GAIA entered into a distribution partnership with the pharmaceutical company Servier Germany in 2015. GAIA is now bringing the marketing of its digital therapy deprexis back in-house as of June 1, 2024. The DiGA manufacturer GAIA is planning its own sales unit for its DiGA products deprexis, priovi and Velibra.
LINK